{
  "docId": "019de515-1bf5-75fc-a19f-ef7a3323e229",
  "docSlug": "a43786f91ea3b101a0e62521077ddab4",
  "documentTitle": "Adagio Therapeutics | Investor Conference Presentation Deck | 14 slides",
  "authorId": "adagio-therapeutics",
  "authorName": "Adagio Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 14,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-1bf5-75fc-a19f-ef7a3323e229/5",
  "deckHref": "/decks/019de515-1bf5-75fc-a19f-ef7a3323e229",
  "deckJsonHref": "/decks/019de515-1bf5-75fc-a19f-ef7a3323e229.json",
  "deckAnchorHref": "/decks/019de515-1bf5-75fc-a19f-ef7a3323e229#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.289,
        "w": 0.19,
        "x": 0.716,
        "y": 0.416
      },
      "kind": "list",
      "text": "Growing number of antibodies aiming to overcome SARS-CoV-2 viral evolution\nPlans to expand into other respiratory viruses with ongoing discovery campaigns in influenza",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "059c3e67-79f6-44a0-8957-b341b755cdd9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.289,
        "w": 0.19,
        "x": 0.29,
        "y": 0.416
      },
      "kind": "list",
      "text": "Rapid repeated antibody isolation, engineering, and predictive modeling of viral evolution\nCandidate optimization for potency, half-life, potential to resist escape, and ease of manufacture",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ac25025-3218-4b95-a534-f6eb7d59fe65",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.46,
        "w": 0.19,
        "x": 0.503,
        "y": 0.416
      },
      "kind": "list",
      "text": "VYD222: a monoclonal antibody for prevention or treatment of COVID-19\nEngineered from adintrevimab (ADG20), which has robust safety data package\nPhase 1 clinical trial start planned for Q1 2023\nVYD224, Candidate 3, Candidate 4: additional monoclonal antibodies for prevention or treatment of COVID-19",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80a0211a-e8c8-4a39-a115-3b839d127260",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.189,
        "x": 0.077,
        "y": 0.416
      },
      "kind": "list",
      "text": "Antibodies designed to protect humanity from serious viral diseases\nContinuous innovation to address COVID-19 variants of concern",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e122ee07-d45c-41e8-8f89-c694bc55a47f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.622,
        "x": 0.045,
        "y": 0.13
      },
      "kind": "title",
      "text": "INVIVYD: A PLATFORM APPROACH TO INNOVATION",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34528949-6c0a-4c95-856c-1b63f08bf692",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "ccab2ada-1cc8-4c81-9cde-c0f1b2528cce",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitation",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "Slides 4 and 5 agitate the problem by highlighting the need for better solutions.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    },
    {
      "to": 14,
      "from": 5,
      "beatId": "5e0a3ea5-562a-4e0c-9d61-b4223eb1f2a7",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 5-14 present Invivyd as a solution, detailing its approach, technology, and progress.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d3def03c-312d-4999-8437-44a76f4d6117",
      "evidence": "The loop is used to emphasize the need for better COVID-19 treatments.",
      "position": 0,
      "objective": "Highlight the cost of not acting or current limitations",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 14,
      "from": 5,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "0486a116-46a3-4832-9ddb-898a5be96dc0",
      "evidence": "The loop is visible in how Invivyd's platform is positioned to meet treatment needs.",
      "position": 1,
      "objective": "Show how Invivyd addresses specific jobs or needs in COVID-19 treatment",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.6,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}